Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens

Soares, Ana Karine de Araújo; Neves, Patrícia Areias Feitosa; Cavalcanti, Maria da Glória Aureliano de Melo; Marinho, Sílvia Martins; Oliveira, Wilson de; Souza, Joelma Rodrigues de; Lorena, Virginia Maria Barros de; Gomes, Yara de Miranda.
Artículo en Inglés | ARCA | ID: arc-18782

Documentos relacionados

  1. [Chagas disease: tackling the invisibility through the analysis of life histories of chronic patients].
  2. Chronic Chagas Disease in the US.
  3. Biomarkers for the diagnosis, treatment follow-up, and prediction of cardiac complications in Chagas disease in chronic phase: Recent advances.
  4. B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi-Specific Antibody-Secreting Cells Following Successful Etiological Treatment.
  5. Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.
  6. Diminished Prolinemia in Chronic Chagasic Patients: A New Clue for Disease Pathology?
  7. Is a negative correlation between sTNFR1 and TNF in patients with chronic Chagas disease the key to clinical progression?
  8. Prognosis of chronic Chagas heart disease and other pending clinical challenges.
  9. Chronic Chagas disease: from basics to laboratory medicine.
  10. Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia.